{"id":"W7110187874","doi":"10.1080/23995270.2025.2580913","title":"AIRLEAF <sup>®</sup> –a study of verducatib as a new kind of treatment for bronchiectasis: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; Grifols; Vertex Pharmaceuticals; AstraZeneca; CSL Behring; Chiesi Farmaceutici; Sanofi; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Pfizer; Bundesministerium für Bildung und Forschung; Insmed; McGill University; Gilead Sciences; Boehringer Ingelheim","keywords":"Bronchiectasis; Exacerbation; Plain language; Placebo; Disease; Pill; Lung disease; Quality of life (healthcare)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006286788,0.0007498022,0.002039896,0.0005455615,0.0004489256,0.002917083,0.0009885136,0.002462898,0.03518908],"category_scores_gemma":[0.008986559,0.000431395,0.002476517,0.0004988991,0.000527623,0.001354748,0.0006051666,0.002915739,0.007434683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008291762,"about_ca_system_score_gemma":0.001743375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001345849,"about_ca_topic_score_gemma":0.002565211,"domain_scores_codex":[0.9979765,0.001107595,0.0003813849,0.0001117802,0.0003229828,0.00009971115],"domain_scores_gemma":[0.9897085,0.006520458,0.001631477,0.0001994718,0.001338851,0.0006012329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05010369,0.001348514,0.001362604,0.06595235,0.002430777,0.000730212,0.0003315825,0.0003754549,0.003953535,0.003272614,0.5195997,0.350539],"study_design_scores_gemma":[0.03654426,0.02996414,0.009205609,0.03640067,0.004783674,0.0007927689,0.0004627515,0.0003993573,0.002463827,0.003419786,0.8753459,0.0002172158],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.02084761,0.745128,0.001643437,0.1355284,0.03679933,0.004881068,0.01538611,0.000336145,0.03944989],"genre_scores_gemma":[0.07247771,0.5363038,0.00552784,0.2421618,0.0619472,0.00725295,0.009909865,0.0003122395,0.06410655],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03518908,"threshold_uncertainty_score":0.1177192,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01042191738904794,"score_gpt":0.3327368808179552,"score_spread":0.3223149634289072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}